This Day On The Street
Continue to site
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

Oracle: Is It Time to Throw in the Towel?

Oracle will also continue to reinvest some of this money in the future growth of its business and the company has demonstrated an above-average ability to execute successful acquisitions. Though there have been missteps, more often than not the company has maintained discipline and focus in its acquisition strategy. I expect its acquisition strategy to continue to be a net positive for shareholders going forward.

Finally, the recent announcements of partnerships with Salesforce.com, Microsoft and NetSuite (N) provide some hope that outright competition in this space may give way to more co-opetition. I don't think any of these partnerships are true game changers for Oracle, but I do think they signal the initiation of a new phase in the dynamics of this market.

So, what is the bottom line? I think current owners of Oracle stock that have endured a rocky first half of the year will do well to stay the course. For those without a position in stock, I think Oracle is particularly interesting at current levels. If the company can steady its business execution, continue its shareholder-friendly cash deployment, and maintain discipline and prudence in its acquisition strategy then I will remain constructive on Oracle stock. If any of these elements dissipate then my interest in owning the stock will quickly fade.

--Written by Craig Gentry, chief investment strategist at Destination Wealth Management.

The author has no personal ownership or investment banking relationships.

Craig Gentry is Executive Vice President and Chief Investment Strategist at Destination Wealth Management.
2 of 2

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Options Profits

Our options trading pros provide over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • Actionable options commentary and news
  • Real-time trading community
SYM TRADE IT LAST %CHG
AAPL $132.54 0.00%
CRM $75.01 0.00%
CVX $104.89 0.00%
ORCL $43.93 0.00%
WDAY $92.18 0.00%

Markets

DOW 18,232.02 -53.72 -0.29%
S&P 500 2,126.06 -4.76 -0.22%
NASDAQ 5,089.3620 -1.4320 -0.03%

Partners Compare Online Brokers

Free Reports

Top Rated Stocks Top Rated Funds Top Rated ETFs